These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 21366526)
1. Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action. Shin JK; Malone DT; Crosby IT; Capuano B Curr Med Chem; 2011; 18(9):1380-404. PubMed ID: 21366526 [TBL] [Abstract][Full Text] [Related]
2. Schizophrenia: genesis, receptorology and current therapeutics. Capuano B; Crosby IT; Lloyd EJ Curr Med Chem; 2002 Mar; 9(5):521-48. PubMed ID: 11945123 [TBL] [Abstract][Full Text] [Related]
3. [Current concepts of the effects of neuroleptics]. Kostowski W; Płaźnik A Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397 [No Abstract] [Full Text] [Related]
4. Novel targets for drugs in schizophrenia. Stone JM; Pilowsky LS CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):265-72. PubMed ID: 17691983 [TBL] [Abstract][Full Text] [Related]
5. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. Kuroki T; Nagao N; Nakahara T Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034 [TBL] [Abstract][Full Text] [Related]
6. Developments in the drug treatment of schizophrenia. Reynolds GP Trends Pharmacol Sci; 1992 Mar; 13(3):116-21. PubMed ID: 1349447 [TBL] [Abstract][Full Text] [Related]
9. Current and novel approaches to the drug treatment of schizophrenia. Rowley M; Bristow LJ; Hutson PH J Med Chem; 2001 Feb; 44(4):477-501. PubMed ID: 11170639 [No Abstract] [Full Text] [Related]
10. Pathology and drug action in schizophrenia: insights from molecular biology. Strange PG Essays Biochem; 1998; 33():105-16. PubMed ID: 10488445 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in the discovery of novel antipsychotic agents modualating dopamine and serotonin receptors. Li X; Ma S Curr Drug Targets; 2013 Jul; 14(8):899-918. PubMed ID: 23701299 [TBL] [Abstract][Full Text] [Related]
13. Neuroreceptor imaging in psychiatric disorders. Frankle WG; Laruelle M Ann Nucl Med; 2002 Nov; 16(7):437-46. PubMed ID: 12508833 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D4 receptors: a new opportunity for research on schizophrenia. Liégeois J; Eyrolles L; Bruhwyler J; Delarge J Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035 [TBL] [Abstract][Full Text] [Related]
16. A computational perspective on drug discovery and signal transduction mechanism of dopamine and serotonin receptors in the treatment of schizophrenia. Lian P; Xu L; Geng C; Qian Y; Li W; Zhen X; Fu W Curr Pharm Biotechnol; 2014; 15(10):916-26. PubMed ID: 25213308 [TBL] [Abstract][Full Text] [Related]
17. Atypical neuroleptics in children and adolescents. Scahill L; Lynch KA J Child Adolesc Psychiatr Nurs; 1998; 11(1):38-43. PubMed ID: 9611543 [No Abstract] [Full Text] [Related]
18. An overview on benzylisoquinoline derivatives with dopaminergic and serotonergic activities. Cabedo N; Berenguer I; Figadère B; Cortes D Curr Med Chem; 2009; 16(19):2441-67. PubMed ID: 19601791 [TBL] [Abstract][Full Text] [Related]